Gyógyszerészi Klinikai Alapismeretek Tanszék

1.

Ratku, B., Lőrincz, H., Csiha, S., Biró, L., Erdei, A., Berta, E., Ujvárosy, D., Bodor, M., Nagy, E. V., Szabó, Z., Harangi, M., Somodi, S.: Alterations of lipoprotein subfractions in GH-deficient adults.
Front Endocrinol (Lausanne). 16, 1-14, 2025.

doi DEA

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism (2024)

2.

Nagy, D. T., Fülesdi, B., Kozma, B., Páll, D., Szatmári, S., Hupuczi, P.: Assessment of Cerebral Hemodynamic Changes During Roll-Over Test in Healthy Pregnant Women and Those with Mild and Severe Preeclampsia.
J Clin Med. 14 (4), 1-9, (article identifier: 1182), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous) (2024)

3.

Dániel, E., Sztanek, F., Csiha, S., Ratku, B., Somodi, S., Paragh, G., Harangi, M., Lőrincz, H.: Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: results from a One-Year Study in Type 2 Diabetes.
Int. J. Mol. Sci. 26 (21), 1-14, (article identifier: 10404), 2025.

doi DEA

Journal metrics:

Q2 Catalysis (2024)

Q1 Computer Science Applications (2024)

Q1 Inorganic Chemistry (2024)

Q1 Medicine (miscellaneous) (2024)

Q2 Molecular Biology (2024)

D1 Organic Chemistry (2024)

Q1 Physical and Theoretical Chemistry (2024)

D1 Spectroscopy (2024)

4.

Vass, A., Király, J., Szabó, E., Shree, N., Ramos, D., Choudhury, M., Fodor, P., Szegedi, K., Halmos, G., Szabó, Z.: Potential Regulatory Role of miR-15b, miR-99b, and miR-181a of the Shikonin-Induced MAPK/ERK Apoptotic Signaling Pathway in Renal Carcinoma.
Biomedicines. 13 (12), 1-22, (article identifier: 2898), 2025.

doi DEA

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)

Q1 Medicine (miscellaneous) (2024)

5.

Tóth, L., Harsányi, A., Csiha, S., Molnár, Á., Lőrincz, H., Nagy, A. C., Paragh, G., Harangi, M., Sztanek, F.: Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: insights from a One-Year Follow-Up Study.
Int. J. Mol. Sci. 26 (13), 1-18, (article identifier: 5951), 2025.

doi DEA WoS

Journal metrics:

Q2 Catalysis (2024)

Q1 Computer Science Applications (2024)

Q1 Inorganic Chemistry (2024)

Q1 Medicine (miscellaneous) (2024)

Q2 Molecular Biology (2024)

D1 Organic Chemistry (2024)

Q1 Physical and Theoretical Chemistry (2024)

D1 Spectroscopy (2024)

6.

Tósaki, Á., Szabó, Z., Király, J., Lőrincz, E. B., Vass, V., Tánczos, B., Bereczki, I., Herczegh, P., Remenyik, É., Tósaki, Á., Szabó, E.: A new cannabigerol derivative, LE-127/2, induces autophagy mediated cell death in human cutaneous melanoma cells.
Eur. J. Pharm. Sci. 203, 1-15, (article identifier: 106920), 2024.

doi DEA Scopus

Journal metrics:

Q1 Pharmaceutical Science

7.

Hermenean, A., Dossi, E., Hamilton, A., Trotta, M. C., Russo, M., Lepre, C. C., Sajtos, C., Rusznyák, Á., Váradi, J., Bácskay, I., Budai, I., D'Amico,, M., Fenyvesi, F.: Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin-Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics.
Pharmaceuticals (Basel). 17 (1), 1-20, (article identifier: 107), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

8.

Király, J., Szabó, E., Fodor, P., Vass, A., Choudhury, M., Gesztelyi, R., Szász, C., Flaskó, T., Dobos, N., Zsebik, B., Steli, Á. J., Halmos, G., Szabó, Z.: Expression of hsa-miRNA-15b, -99b, -181a and Their Relationship to Angiogenesis in Renal Cell Carcinoma.
Biomedicines. 12 (7), 1-18, (article identifier: 1441), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

9.

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (article identifier: 565), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Endocrinology, Diabetes and Metabolism

Q2 Molecular Biology

10.

Ratku, B., Lőrincz, H., Csiha, S., Borbásné Sebestyén, V., Berta, E., Bodor, M., Nagy, E. V., Szabó, Z., Harangi, M., Somodi, S.: Serum afamin and its implications in adult growth hormone deficiency: a prospective GH-withdrawal study.
Front Endocrinol (Lausanne). 15, 1-13, (article identifier: 1348046), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

11.

Halmi, S., Berta, E., Diószegi, Á., Sira, L., Fülöp, P., Nagy, E. V., Győry, F., Kanyári, Z., Tóth, J., Bhattoa, H. P., Bodor, M.: Single center experience in localization of insulinoma by selective intraarterial calcium stimulation angiography: a case series of 15 years.
Front Endocrinol (Lausanne). 15, 1-7, (article identifier: 1305958), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

12.

Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14, 1-9, (article identifier: 1187725), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

13.

Bodor, M., Mezősi, E.: Editorial: Thyroid function and its interaction with metabolic molecules.
Front Endocrinol (Lausanne). 14 (9), 1-2, 2023.

doi DEA WoS Scopus

14.

Berta, E., Lengyel, I., Hegedűs, L., Papini, E., Perros, P., Negro, R., Attanasio, R., Nagy, E. V., Bodor, M.: Pajzsmirigyhormon-kezelési szokások Magyarországon.
Orv. hetil. 163 (12), 463-472, 2022.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

15.

Pető, Á., Kósa, D., Haimhoffer, Á., Fehér, P., Ujhelyi, Z., Sinka, D. Z., Fenyvesi, F., Váradi, J., Vecsernyés, M., Gyöngyösi, A., Lekli, I., Szentesi, P., Marton, A., Gombos, I., Dukic, B., Vígh, L., Bácskay, I.: Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect.
Pharmaceutics. 13 (12), 2037, (article identifier: 2037), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

16.

Lódi, M., Bánhegyi, V., Bódi, B., Gyöngyösi, A., Kovács, Á., Árokszállási, A., Hamdani, N., Fagyas, M., Édes, I., Csanádi, Z., Czuriga, I., Kisvárday, Z., Lekli, I., Bai, P., Tóth, A., Papp, Z., Czuriga, D.: Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 18 (1), 470, (article identifier: 470), 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

17.

Lódi, M., Priksz, D., Fülöp, G. Á., Bódi, B., Gyöngyösi, A., Nagy, L., Kovács, Á., Kertész, A. B., Kocsis, J., Édes, I., Csanádi, Z., Czuriga, I., Kisvárday, Z., Juhász, B., Lekli, I., Bai, P., Tóth, A., Papp, Z., Czuriga, D.: Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 17, 229, (article identifier: 229), 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

18.

Tóth, H., Fésüs, A., Kungler-Gorácz, O., Balázs, B., Majoros, L., Szarka, K., Kardos, G.: Utilization of vector autoregressive and linear transfer models to follow up the antibiotic resistance spiral in Gram-negative bacteria from cephalosporin consumption to colistin resistance.
Clin. Infect. Dis. 69 (8), 1410-1421, 2019.

doi DEA WoS Scopus

Journal metrics:

D1 Infectious Diseases

D1 Microbiology (medical)

19.

Berta, E., Bodor, M., Galuska, L., Paragh, G., Erdei, A., Gazdag, A., Ujhelyi, B., Berényi, E., Katkó, M., Gazsó, A., Nagy, E. V.: Early stage Graves' disease is uniformly accompanied by orbital immune activity even in patients who fail to develop orbithopathy during follow-up.
Exp. Clin. Endocrinol. Diabet. 126 (10), 628-631, 2018.

doi DEA

Journal metrics:

Q3 Endocrinology

Q3 Endocrinology, Diabetes and Metabolism

Q2 Internal Medicine

Q2 Medicine (miscellaneous)

20.

Somodi, S., Seres, I., Lőrincz, H., Harangi, M., Fülöp, P., Paragh, G.: Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese non-diabetic subjects.
Int. J. Endocrinol. 2018, 1-9, 2018.

DEA

Journal metrics:

Q2 Endocrine and Autonomic Systems

Q2 Endocrinology

Q2 Endocrinology, Diabetes and Metabolism

21.

Csige, I., Ujvárosy, D., Szabó, Z., Lőrincz, I., Paragh, G., Harangi, M., Somodi, S.: The Impact of Obesity on the Cardiovascular System.
J. Diabetes Res. 2018, 1-12, 2018.

doi DEA

Journal metrics:

Q2 Endocrinology

Q2 Endocrinology, Diabetes and Metabolism

22.

Erdei, A., Steiber, Z., Gazdag, A., Bodor, M., Berta, E., Szász, R., Szántó, A., Ujhelyi, B., Barna, S., Berényi, E., Nagy, E. V.: Az endokrin orbitopathia differenciáldiagnosztikája.
Orvosi Hetilap. 157 (8), 310-315, 2016.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

23.

Bodor, M.: Bizonyos gyógyszerek hatása az endokrin rendszerre.
In: Az endokrin és anyagcsere-betegségek gyakorlati kézikönyve (2. bővített kiadás). Szerk.: Leövey A., Nagy V. E., Paragh Gy., Rácz K, Medicina Könyvkiadó Zrt., Budapest, 710-713, 2016. ISBN: 9789632266121

DEA

24.

Berta, E., Harangi, M., Varga, V. E., Lórincz, H., Seres, I., Nagy, E. V., Paragh, G., Bodor, M.: Evaluation of serum chemerin level in patients with Hashimoto's thyroiditis.
Atherosclerosis. 252, e168, 2016.

doi DEA WoS

25.

Zsuga, J., Tajti, G., Papp, C., Juhász, B., Gesztelyi, R.: FNDC5/irisin, a molecular target for boosting reward-related learning and motivation.
Med. Hypotheses. 90, 23-28, 2016.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Gyógyszerészi Klinikai Alapismeretek Tanszék

Publication list